These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11554586)

  • 1. CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor production.
    Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Key NS; Conti-Fine BM
    Adv Exp Med Biol; 2001; 489():119-34. PubMed ID: 11554586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives.
    Ananyeva NM; Lacroix-Desmazes S; Hauser CA; Shima M; Ovanesov MV; Khrenov AV; Saenko EL
    Blood Coagul Fibrinolysis; 2004 Mar; 15(2):109-24. PubMed ID: 15090997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects.
    Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Key NS; Conti-Fine BM
    Thromb Haemost; 1999 Aug; 82(2):509-15. PubMed ID: 10605744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
    Hu G; Guo D; Key NS; Conti-Fine BM
    Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients.
    Reding MT; Lei S; Lei H; Green D; Gill J; Conti-Fine BM
    Thromb Haemost; 2002 Oct; 88(4):568-75. PubMed ID: 12362225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.
    Sasgary M; Ahmad RU; Schwarz HP; Turecek PL; Reipert BM
    Thromb Haemost; 2002 Feb; 87(2):266-72. PubMed ID: 11858486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII inhibitors.
    Lollar P; Healey JF; Barrow RT; Parker ET
    Adv Exp Med Biol; 2001; 489():65-73. PubMed ID: 11554592
    [No Abstract]   [Full Text] [Related]  

  • 10. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.
    Matino D; Gargaro M; Santagostino E; Di Minno MN; Castaman G; Morfini M; Rocino A; Mancuso ME; Di Minno G; Coppola A; Talesa VN; Volpi C; Vacca C; Orabona C; Iannitti R; Mazzucconi MG; Santoro C; Tosti A; Chiappalupi S; Sorci G; Tagariello G; Belvini D; Radossi P; Landolfi R; Fuchs D; Boon L; Pirro M; Marchesini E; Grohmann U; Puccetti P; Iorio A; Fallarino F
    J Clin Invest; 2015 Oct; 125(10):3766-81. PubMed ID: 26426076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.
    Prescott R; Nakai H; Saenko EL; Scharrer I; Nilsson IM; Humphries JE; Hurst D; Bray G; Scandella D
    Blood; 1997 May; 89(10):3663-71. PubMed ID: 9160671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of inhibitors in hemophilia A and the induction of immune tolerance.
    Briët E; Peters M
    Adv Exp Med Biol; 2001; 489():89-97. PubMed ID: 11554594
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A.
    Madoiwa S; Yamauchi T; Kobayashi E; Hakamata Y; Dokai M; Makino N; Kashiwakura Y; Ishiwata A; Ohmori T; Mimuro J; Sakata Y
    J Thromb Haemost; 2009 May; 7(5):811-24. PubMed ID: 19220731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
    Hu GL; Okita DK; Conti-Fine BM
    J Thromb Haemost; 2004 Nov; 2(11):1908-17. PubMed ID: 15550021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological aspects of inhibitor development.
    Reding MT
    Haemophilia; 2006 Dec; 12 Suppl 6():30-5; discussion 35-6. PubMed ID: 17123391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
    Chen Y; Luo X; Schroeder JA; Chen J; Baumgartner CK; Hu J; Shi Q
    J Thromb Haemost; 2017 Oct; 15(10):1994-2004. PubMed ID: 28799202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
    Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S
    Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.
    Waters B; Qadura M; Burnett E; Chegeni R; Labelle A; Thompson P; Hough C; Lillicrap D
    Blood; 2009 Jan; 113(1):193-203. PubMed ID: 18815284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune mechanisms involved in the development and eradication of anti-factor VIII alloantibodies in hemophilia].
    Ishiguro A
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(6):476-84. PubMed ID: 22214808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
    Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
    Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.